Purchase Order HHSN302201700178P

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. for $8,745.00 on December 19, 2017, with completion by January 2, 2019. No set-aside was applied. Work is performed in Bethesda, Maryland. The order uses firm fixed-price pricing for commercial bioinformatics software licenses and analytical tools to support genomic data analysis and research at the institute.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. for $6,991.00 on May 23, 2018, with completion by August 1, 2019. No set-aside was used. Work is performed at Bethesda, Maryland. The order is for firm fixed-price procurement of genomic data analysis software or services supporting federal research operations.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $6,708.01 on July 13, 2018, with an ultimate completion date of August 12, 2018. Performance occurs in North Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific line items or procurement scope are not detailed in the award record.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 30, 2017, with a ceiling value of $7,216.30 for genomic analysis equipment and services.</p> <p>Place of performance is North Bethesda, MD. The order is priced on a firm fixed-price basis and has an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>